-SEC Filing
Lexicon Pharmaceuticals Q2 EPS $(0.16), Inline, Sales $35.00K Miss $50.00K Estimate
Lexicon Pharmaceuticals (NASDAQ:LXRX) reported quarterly losses of $(0.16) per share which met the analyst consensus estimate. This is a 23.08 percent decrease over losses of $(0.13) per share from the same period last